Acadia Pharmaceuticals Inc.
ACAD stock score: 52/100
$20.31 · +0.59% · Scored Oct 22, 2026
- Technical
- 38
- Fundamental
- 66
- News
- —
The reading
Acadia Pharmaceuticals (ACAD) scores 52 out of 100, which reads neutral, higher than 68% of Healthcare stocks and 49% of the 4,161 US stocks we score.
The composite is technicals and fundamentals weighted equally: technicals read 38, fundamentals 66.
Among the fundamentals, Fair Value at 100 and Revenue Quality (Quarterly) at 100 score highest, while Revenue Growth (5-Year) at 0 weighs the most against it.
On the daily chart, trend-following indicators average 35 and contrarian oscillators 49.
Since Jul 25, 2026 the composite has ranged from 49 to 76, and it is down 20 points over the period.
What’s driving the score
The strongest and weakest of the scorers that count toward ACAD’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
66Pulling it up
- Fair Value100
Fair value score synthesizes multiple valuation methods (DCF, P/E, P/B, P/S) to estimate intrinsic worth.
- Revenue Quality (Quarterly)100
Revenue Quality (Quarterly) evaluates recent revenue performance using trailing 12-month data from quarterly reports.
- Earnings Growth (Annual)99
Annual earnings growth tracks year-over-year profit expansion.
Holding it back
- Revenue Growth (5-Year)0
5-year revenue growth analyzes long-term sales trajectory and consistency.
- PEG Ratio0
PEG ratio divides the P/E ratio by earnings growth rate.
- Fund Ownership7
Fund ownership tracks institutional investor holdings and changes.
40 weighted scorers; 1 had no data today and are left out rather than counted as zero.
Technical · daily
34Pulling it up
- Parabolic SAR (PSAR)100
Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.
- Candlestick Patterns100
Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.
- MACD (12)85
Moving Average Convergence Divergence tracks the relationship between two exponential moving averages.
Holding it back
- Ichimoku Cloud0
Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.
- SMA 1000
Simple Moving Average (100-period) provides a longer-term perspective on price trends.
- SMA 500
Simple Moving Average (50-period) is a widely-watched intermediate-term trend gauge.
62 weighted scorers; 3 had no data today and are left out rather than counted as zero.
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 56 | 1 |
| Daily | 34 | 3 |
| Weekly | 31 | 2 |
| Monthly | 40 | 2 |
| Quarterly | 38 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Oct 22, 2026 | 52 |
| Oct 21, 2026 | 52 |
| Oct 20, 2026 | 52 |
| Oct 19, 2026 | 51 |
| Oct 18, 2026 | 49 |
| Oct 17, 2026 | 49 |
| Oct 16, 2026 | 49 |
| Oct 15, 2026 | 51 |
| Oct 14, 2026 | 50 |
| Oct 13, 2026 | 50 |
| Oct 12, 2026 | 50 |
| Oct 11, 2026 | 51 |
| Oct 10, 2026 | 51 |
| Oct 9, 2026 | 51 |
| Oct 8, 2026 | 50 |
| Oct 7, 2026 | 50 |
| Oct 6, 2026 | 50 |
| Oct 5, 2026 | 51 |
| Oct 4, 2026 | 50 |
| Oct 3, 2026 | 50 |
| Oct 2, 2026 | 51 |
| Oct 1, 2026 | 49 |
| Sep 30, 2026 | 50 |
| Sep 29, 2026 | 50 |
| Sep 28, 2026 | 50 |
| Sep 27, 2026 | 51 |
| Sep 26, 2026 | 51 |
| Sep 25, 2026 | 51 |
| Sep 24, 2026 | 55 |
| Sep 23, 2026 | 62 |
| Sep 22, 2026 | 62 |
| Sep 21, 2026 | 61 |
| Sep 20, 2026 | 62 |
| Sep 19, 2026 | 62 |
| Sep 18, 2026 | 62 |
| Sep 17, 2026 | 64 |
| Sep 16, 2026 | 63 |
| Sep 15, 2026 | 61 |
| Sep 14, 2026 | 64 |
| Sep 13, 2026 | 63 |
| Sep 12, 2026 | 63 |
| Sep 11, 2026 | 64 |
| Sep 10, 2026 | 62 |
| Sep 9, 2026 | 64 |
| Sep 8, 2026 | 64 |
| Sep 7, 2026 | 64 |
| Sep 6, 2026 | 63 |
| Sep 5, 2026 | 63 |
| Sep 4, 2026 | 64 |
| Sep 3, 2026 | 63 |
| Sep 2, 2026 | 65 |
| Sep 1, 2026 | 65 |
| Aug 31, 2026 | 65 |
| Aug 30, 2026 | 64 |
| Aug 29, 2026 | 65 |
| Aug 28, 2026 | 64 |
| Aug 27, 2026 | 65 |
| Aug 26, 2026 | 65 |
| Aug 25, 2026 | 67 |
| Aug 24, 2026 | 66 |
| Aug 23, 2026 | 66 |
| Aug 22, 2026 | 66 |
| Aug 20, 2026 | 65 |
| Aug 19, 2026 | 68 |
| Aug 18, 2026 | 66 |
| Aug 17, 2026 | 66 |
| Aug 16, 2026 | 65 |
| Aug 15, 2026 | 65 |
| Aug 14, 2026 | 65 |
| Aug 13, 2026 | 66 |
| Aug 12, 2026 | 66 |
| Aug 11, 2026 | 67 |
| Aug 10, 2026 | 67 |
| Aug 9, 2026 | 67 |
| Aug 8, 2026 | 67 |
| Aug 7, 2026 | 66 |
| Aug 6, 2026 | 61 |
| Aug 5, 2026 | 61 |
| Aug 3, 2026 | 59 |
| Aug 2, 2026 | 59 |
| Jul 31, 2026 | 75 |
| Jul 30, 2026 | 75 |
| Jul 29, 2026 | 75 |
| Jul 28, 2026 | 76 |
| Jul 27, 2026 | 75 |
| Jul 26, 2026 | 72 |
| Jul 25, 2026 | 72 |
Key facts
- Market cap
- $3.5B
- Sector
- Healthcare
- Industry
- Biotechnology
- Beta
- 0.89
- Risk grade (1–10)
- 4
- Next earnings
- Nov 4, 2026
Biotechnology peers
| Company | Market cap | Score |
|---|---|---|
| ABCL AbCellera Biologics | $3.7B | 50 |
| LEGN Legend Biotech | $3.7B | 41 |
| XENE Xenon Pharmaceuticals | $3.5B | 36 |
| IDYA IDEAYA Biosciences | $3.5B | 50 |
| TARS Tarsus Pharmaceuticals | $3.4B | 52 |
| VKTX Viking Therapeutics | $3.3B | 32 |
Questions
What is ACAD's stock score today?
ACAD scores 52/100 (Neutral) as of Oct 22, 2026: technical 38, fundamental 66. Scores are recomputed every night.
Is ACAD a buy?
The score is not a buy or sell recommendation. A 52 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the ACAD score calculated?
102 weighted scorers feed it today: 40 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.